In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Bryan Williams
Speaker
Bryan Williams
Bryan Williams Bryan Williams

University College London, London (United Kingdom of Great Britain & Northern Ireland)

Specialities : Hypertension , Research Methodology

Bryan Williams is Chair of Medicine at University College London (UCL) and Director of the National Institutes for Health Research (NIHR) UCL Hospitals Biomedical Research Centre and Director of Research for UCL Hospitals where he is a Consultant Physician, member of the Senior Directors Team and Board Member. Professor Williams research and clinical practice in the field of high blood pressure has led him to be recognised as one of the world's leading authorities and through which he has led or participated in many national and international clinical trials that have changed clinical practice. He leads one of the largest Biomedical Research Centres in Europe. He is immediate past-Chairman of the ESC Council on Hypertension and ESC Chairman of the ESC/ESH Hypertension guideline task force (2018) and was Chairman of the NICE Hypertension Guidelines Development Group (published in 2011). He is the past President of the British Hypertension Society (2001–2003).

74 presentations from this speaker

Blood pressure target to <120 /<70 mmHg associates with poor outcome - PRO

Event : ESC Congress 2019

  • Session : Controversies in hypertension management
  • Speaker : B Williams (London,GB)

Different recommendations on blood pressure targets: rationale for embracing ESC guidelines

Event : ESC Congress 2019

  • Session : Primary prevention revolution
  • Speaker : B Williams (London,GB)

Discussion

Event : ESC Congress 2019

  • Session : Innovative development in watch-type wearable SMART blood pressure monitoring and its clinical application
  • Speaker : B Williams (London,GB)
  • Sponsored by OMRON Healthcare Europe

Introduction

Event : ESC Congress 2019

  • Session : Innovative development in watch-type wearable SMART blood pressure monitoring and its clinical application
  • Speaker : B Williams (London,GB)
  • Sponsored by OMRON Healthcare Europe

Introduction and aims

Event : ESC Congress 2019

  • Session : Beta blockers are not a homogeneous class
  • Speaker : B Williams (London,GB)
  • Sponsored by Menarini Group

Lifestyle, drugs, and devices

Event : ESC Congress 2019

  • Session : The year in hypertension : hot papers 2018/2019
  • Speaker : B Williams (London,GB)

State of the Art - Drug treatment in hypertension: unmet needs

Event : ESC Congress 2019

  • Session : Drug treatment in hypertension - New insights
  • Speaker : B Williams (London,GB)

Why a new treatment algorithm?

Event : ESC Congress 2019

  • Session : Hypertension management: behind the scenes of 2018 ESH/ESC guidelines
  • Speaker : B Williams (London,GB)
  • Sponsored by Menarini Group and Daiichi Sankyo Europe GmbH

2018 ESC/ESH Guidelines on Arterial Hypertension – Part 1.

Event : ESC Congress 2018

  • Session : ESC 2018 Guidelines Overview
  • Speaker : B Williams (London,GB)

Arterial hypertension.

Event : ESC Congress 2018

  • Session : Meet the Task Force of the 2018 ESC/ESH Guidelines on Arterial Hypertension
  • Speaker : B Williams (London,GB)

Closing remarks

Event : ESC Congress 2018

  • Session : Hypertension guidelines in Europe and the US: treatment targets for the elderly
  • Speaker : B Williams (London,GB)

Discussion - Evolving approaches to the management of hypertension: combination therapy for all?

Event : ESC Congress 2018

  • Session : Evolving approaches to the management of hypertension: combination therapy for all?
  • Speaker : R Castillo (Makati,PH), S Laurent (Paris,FR), R Schmieder (Erlangen,DE), B Williams (London,GB)
  • Sponsored by SERVIER

Everybody with a blood pressure above 130/80 is hypertensive - CON.

Event : ESC Congress 2018

  • Session : Must hypertension be redefined?
  • Speaker : B Williams (London,GB)
  • Great Debate

Everybody with a blood pressure above 130/80 is hypertensive - Rebuttal CON.

Event : ESC Congress 2018

  • Session : Must hypertension be redefined?
  • Speaker : B Williams (London,GB)
  • Great Debate

Hypertension treatment – Lifestyle interventions, drug treatment strategies and role of device-base therapy.

Event : ESC Congress 2018

  • Session : 2018 ESC/ESH Guidelines on Arterial Hypertension
  • Speaker : B Williams (London,GB)

Introduction.

Event : ESC Congress 2018

  • Session : Evolving approaches to the management of hypertension: combination therapy for all?
  • Speaker : B Williams (London,GB)
  • Sponsored by SERVIER

Panel discussion on clinical implications.

Event : ESC Congress 2018

  • Session : Implementing the new European hypertension guidelines into clinical practice
  • Speaker : B Williams (London,GB), R Castillo (Makati,PH), T Unger (Heidelberg,DE), F Messerli (Bern,CH)
  • Sponsored by Boehringer Ingelheim International GmbH

Summary and close - Implementing the new European hypertension guidelines into clinical practice.

Event : ESC Congress 2018

  • Session : Implementing the new European hypertension guidelines into clinical practice
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim International GmbH

The latest thinking in hypertension drug treatment strategy.

Event : ESC Congress 2018

  • Session : Implementing the new European hypertension guidelines into clinical practice
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim International GmbH

Welcome and introduction - Implementing the new European hypertension guidelines into clinical practice.

Event : ESC Congress 2018

  • Session : Implementing the new European hypertension guidelines into clinical practice
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim International GmbH

Are screening programmes for hypertension efficient?

Event : ESC Congress 2017

  • Session : 3 out of 4 hypertensive patients not controlled over 24 hours: what are the solutions?
  • Speaker : B Williams (London,GB)
  • Sponsored by SERVIER

BP control – Can we achieve it?

Event : ESC Congress 2017

  • Session : Expert opinion on blood pressure control and cardiovascular risk
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Conclusion - 3 out of 4 hypertensive patients not controlled over 24 hours: what are the solutions?

Event : ESC Congress 2017

  • Session : 3 out of 4 hypertensive patients not controlled over 24 hours: what are the solutions?
  • Speaker : B Williams (London,GB)
  • Sponsored by SERVIER

Discussant review: SPYRAL HTN OFF-MED Study

Event : ESC Congress 2017

  • Session : Hot Line: Late-Breaking Clinical Trials 2
  • Speaker : B Williams (London,GB)

Discussion - 3 out of 4 hypertensive patients not controlled over 24 hours: what are the solutions?

Event : ESC Congress 2017

  • Session : 3 out of 4 hypertensive patients not controlled over 24 hours: what are the solutions?
  • Speaker : K Narkiewicz (Gdansk,PL), G Stergiou (Athens,GR), C Tsioufis (Athens,GR), B Williams (London,GB)
  • Sponsored by SERVIER

Interactive debate: should there be greater emphasis on combination therapy, particularly fixed-dose combinations, in the treatment guidelines?

Event : ESC Congress 2017

  • Session : Achieving better blood pressure (BP) control with fixed-dose combination (FDC) therapy
  • Speaker : A De La Sierra (Terrassa,ES), B Williams (London,GB), M Burnier (Lausanne,CH), M Volpe (Rome,IT)
  • Sponsored by Menarini group and Daiichi Sankyo Co., Ltd

Introduction - Current challenges in treating hypertensive patients with multiple comorbidities.

Event : ESC Congress 2017

  • Session : Advances in the management of hypertensive patients with multiple risk factors
  • Speaker : B Williams (London,GB)
  • Sponsored by Novartis Pharma AG

Maximising benefits of fixed-dose combinations.

Event : ESC Congress 2017

  • Session : Achieving better blood pressure (BP) control with fixed-dose combination (FDC) therapy
  • Speaker : B Williams (London,GB)
  • Sponsored by Menarini group and Daiichi Sankyo Co., Ltd

Mechanisms for the benefit of spironolactone in resistant hypertension in the PATHWAY-2 study

Event : ESC Congress 2017

  • Session : Clinical Trial Update 1
  • Speaker : B Williams (London,GB)

Panel discussion - Advances in the management of hypertensive patients with multiple risk factors.

Event : ESC Congress 2017

  • Session : Advances in the management of hypertensive patients with multiple risk factors
  • Speaker : B Williams (London,GB), E Agabiti-Rosei (Brescia,IT), S Del Prato (Pisa,IT)
  • Sponsored by Novartis Pharma AG

Panel discussion, summary & close - Expert opinion on blood pressure control and cardiovascular risk.

Event : ESC Congress 2017

  • Session : Expert opinion on blood pressure control and cardiovascular risk
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Treating drug resistant hypertension.

Event : ESC Congress 2017

  • Session : Hypertension in 90 minutes
  • Speaker : B Williams (London,GB)

Treatment strategies for hypertensive patients with multiple risk factors.

Event : ESC Congress 2017

  • Session : Advances in the management of hypertensive patients with multiple risk factors
  • Speaker : B Williams (London,GB)
  • Sponsored by Novartis Pharma AG

Welcome and introduction - Expert opinion on blood pressure control and cardiovascular risk.

Event : ESC Congress 2017

  • Session : Expert opinion on blood pressure control and cardiovascular risk
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Achieving sustained BP control.

Event : ESC Congress 2016

  • Session : Hypertensive care beyond blood pressure
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

An introduction to current challenges and future perspectives in hypertension.

Event : ESC Congress 2016

  • Session : Current challenges and future perspectives in hypertension
  • Speaker : B Williams (London,GB)
  • Sponsored by Novartis Pharma AG

Aortic diasease in hypertension

Event : ESC Congress 2016

  • Session : Diagnosis and management of target organ damage in hypertension
  • Speaker : B Williams (London,GB)
  • Organised by Council on Hypertension

Cardiovascular disease burden: improving patient management.

Event : ESC Congress 2016

  • Session : Three-drug combinations: enhancing effectiveness in high cardiovascular risk patients
  • Speaker : B Williams (London,GB)
  • Organised by SERVIER

Expert panel discussion and audience questions - Current challenges and future perspectives in hypertension.

Event : ESC Congress 2016

  • Session : Current challenges and future perspectives in hypertension
  • Speaker : B Williams (London,GB)
  • Sponsored by Novartis Pharma AG

Hyperkalaemia: pathophysiology, clinical significance and unmet need.

Event : Heart Failure 2016

  • Session : Hyperkalaemia: are your patients missing out?
  • Speaker : B Williams (London,GB)
  • Sponsored by Vifor Pharma

Hypertension

Event : ESC Congress 2016

  • Session : ESC Congress Highlights
  • Speaker : B Williams (London,GB)

Panel discussion - Hypertensive care beyond blood pressure.

Event : ESC Congress 2016

  • Session : Hypertensive care beyond blood pressure
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Should Guidelines "SPRINT" to lower blood pressure targets? - Conclusion.

Event : ESC Congress 2016

  • Session : Should guidelines "SPRINT" to lower blood pressure targets?
  • Speaker : B Williams (London,GB)

Summary and close - Hypertensive care beyond blood pressure.

Event : ESC Congress 2016

  • Session : Hypertensive care beyond blood pressure
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Welcome and introduction - Hypertensive care beyond blood pressure.

Event : ESC Congress 2016

  • Session : Hypertensive care beyond blood pressure
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Assessing large artery function beyond blood pressure.

Event : ESC Congress 2015

  • Session : Arterial stiffness – The Cardio-Ankle Vascular Index (CAVI) from research to clinical practice
  • Speaker : B Williams (London,GB)
  • Sponsored by Fukuda Denshi Co. Ltd.

Chairperson's introduction: what are the key barriers that are holding back improvements in blood pressure control in 2015?

Event : ESC Congress 2015

  • Session : Management of blood pressure control: at the cutting edge
  • Speaker : B Williams (London,GB)
  • Sponsored by The Menarini Group and Daiichi Sankyo Europe GmbH

Challenges in hypertension - Introduction to the session.

Event : ESC Congress 2015

  • Session : Challenges in hypertension
  • Speaker : B Williams (London,GB)

Closing remarks and Q&A - Treatment of hypertension in new frontiers.

Event : ESC Congress 2015

  • Session : Treatment of hypertension in new frontiers
  • Speaker : B Williams (London,GB), GT McInnes (Glasgow,GB)
  • Sponsored by Novartis Pharmaceuticals

Discussion - Patient-centered approach when multiple cardiovascular risks coexist.

Event : ESC Congress 2015

  • Session : Patient-centered approach when multiple cardiovascular risks coexist
  • Speaker : C Vlachopoulos (Athens,GR), B Williams (London,GB), R Ferrari (Ferrara,IT)
  • Organised by Athens Medical School Course Director: Charalambos Vlachopoulos Supported by an unrestricted educational grant from SERVIER

How to achieve treatment goals in patients with multiple cardiovascular risk factors?

Event : ESC Congress 2015

  • Session : Patient-centered approach when multiple cardiovascular risks coexist
  • Speaker : B Williams (London,GB)
  • Organised by Athens Medical School Course Director: Charalambos Vlachopoulos Supported by an unrestricted educational grant from SERVIER

Hypertension.

Event : ESC Congress 2015

  • Session : ESC Congress Highlights
  • Speaker : B Williams (London,GB)

Introduction - Patient-centered approach when multiple cardiovascular risks coexist.

Event : ESC Congress 2015

  • Session : Patient-centered approach when multiple cardiovascular risks coexist
  • Speaker : B Williams (London,GB)
  • Organised by Athens Medical School Course Director: Charalambos Vlachopoulos Supported by an unrestricted educational grant from SERVIER

Introduction - Treatment of hypertension in new frontiers.

Event : ESC Congress 2015

  • Session : Treatment of hypertension in new frontiers
  • Speaker : B Williams (London,GB)
  • Sponsored by Novartis Pharmaceuticals

Managing hypertension – Pill or ablation?

Event : ESC Congress 2015

  • Session : The European Heart Journal‘s year in cardiology: from prevention to intervention
  • Speaker : B Williams (London,GB)

Pharmacological treatment of resistant hypertension

Event : ESC Congress 2015

  • Session : Difficult to treat hypertension
  • Speaker : B Williams (London,GB)
  • ESC and the European Society of Hypertension

The role of hypertension on diabetic microcirculatory damage.

Event : ESC Congress 2015

  • Session : Microcirculatory damage in hypertension
  • Speaker : B Williams (London,GB)

Beta blockers are not first choice for the routine treatment of hypertension. PRO.

Event : ESC Congress 2014

  • Session : Hot topics in hypertension
  • Speaker : B Williams (London,GB)

Beta blockers are not first choice for the routine treatment of hypertension. REBUTTAL PRO.

Event : ESC Congress 2014

  • Session : Hot topics in hypertension
  • Speaker : B Williams (London,GB)

Hypertension.

Event : ESC Congress 2014

  • Session : Highlight session
  • Speaker : B Williams (London,GB)

Managing hypertension - pill or ablation?

Event : ESC Congress 2014

  • Session : The European Heart Journal’s Year in Cardiology: from prevention to intervention
  • Speaker : B Williams (London,GB)

Needs to evaluate arterial stiffness and central BP.

Event : ESC Congress 2014

  • Session : Cardio-ankle vascular index (CAVI) - Establishment of a new global arterial stiffness index
  • Speaker : B Williams (London,GB)
  • Sponsored by Fukuda Denshi

Optimal blood pressure reduction – How fast, how low and for whom?

Event : ESC Congress 2014

  • Session : Cardiovascular risk and new hypertension guidelines – Is blood pressure control enough?
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Pharmacological treatment.

Event : ESC Congress 2014

  • Session : Resistant hypertension in 2014
  • Speaker : B Williams (London,GB)

Summary and close - Cardiovascular risk & new hypertension guidelines – Is blood pressure control enough?

Event : ESC Congress 2014

  • Session : Cardiovascular risk and new hypertension guidelines – Is blood pressure control enough?
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Discussion and summary: why do goal rates in hypertension urgently need to improve?

Event : ESC Congress 2013

  • Session : Why do goal rates in hypertension urgently need to improve?
  • Speaker : B Williams (London,GB)
  • Sponsored by Daiichi Sankyo Europe GmbH and The Menarini Group

Hypertension.

Event : ESC Congress 2013

  • Session : Highlight Session
  • Speaker : B Williams (London,GB)

Optimal blood pressure reduction - How fast, how low and for whom?

Event : ESC Congress 2013

  • Session : Untangling cardiovascular disease prevention - Is blood pressure control enough?
  • Speaker : B Williams (London,GB)
  • Sponsored by Boehringer Ingelheim

Panel discussion.

Event : ESC Congress 2013

  • Session : Challenges in the treatment of hypertension
  • Speaker : G Mancia (Milano,IT), J Mann (Munchen,DE), B Williams (London,GB)

Renal artery stenosis: drug, stent or both?

Event : ESC Congress 2013

  • Session : Challenges in the treatment of hypertension
  • Speaker : B Williams (London,GB)

Why cardiologists should embrace hypertension.

Event : ESC Congress 2013

  • Session : Hypertension is coming home to cardiology
  • Speaker : B Williams (London,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are